Sitagliptin Added-on to Insulin Study (0431-051)

Clinical trial NCT00395343 · COMPLETED

Trial details

NCT number: NCT00395343
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2006-12-11
Primary completion: 2008-10-13
Enrollment: 641

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.